Cancer Nanomedicine
Funding
Conflicts of Interest
References
- Michy, T.; Massias, T.; Bernard, C.; Vanwonterghem, L.; Henry, M.; Guidetti, M.; Royal, G.; Coll, J.; Texier, I.; Josserand, V.; et al. Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo. Cancers 2019, 11, 1760. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, J.; Yoon, D.; Kim, J. Oxidation-Triggerable Liposome Incorporating Poly (Hydroxyethyl Acrylate-co-Allyl methyl sulfide) as an Anticancer Carrier of Doxorubicin. Cancers 2020, 12, 180. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bang, K.; Na, Y.; Huh, H.; Hwang, S.; Kim, M.; Kim, M.; Lee, H.; Cho, C. The Delivery Strategy of Paclitaxel Nanostructured Lipid Carrier Coated with Platelet Membrane. Cancers 2019, 11, 807. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Palazzolo, S.; Hadla, M.; Russo Spena, C.; Caligiuri, I.; Rotondo, R.; Adeel, M.; Kumar, V.; Corona, G.; Canzonieri, V.; Toffoli, G.; et al. An Effective Multi-Stage Liposomal DNA Origami Nanosystem for In Vivo Cancer Therapy. Cancers 2019, 11, 1997. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yakavets, I.; Millard, M.; Lamy, L.; Francois, A.; Scheglmann, D.; Wiehe, A.; Lassalle, H.; Zorin, V.; Bezdetnaya, L. Matryoshka-Type Liposomes Offer the Improved Delivery of Temoporfin to Tumor Spheroids. Cancers 2019, 11, 1366. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Filipczak, N.; Jaromin, A.; Piwoni, A.; Mahmud, M.; Sarisozen, C.; Torchilin, V.; Gubernator, J. A Triple Co-Delivery Liposomal Carrier That Enhances Apoptosis via an Intrinsic Pathway in Melanoma Cells. Cancers 2019, 11, 1982. [Google Scholar] [CrossRef]
- Mahmoud, B.; AlAmri, A.; McConville, C. Polymeric Nanoparticles for the Treatment of Malignant Gliomas. Cancers 2020, 12, 175. [Google Scholar] [CrossRef] [Green Version]
- Nieto, C.; Vega, M.; Enrique, J.; Marcelo, G.; Martín del Valle, E. Size Matters in the Cytotoxicity of Polydopamine Nanoparticles in Different Types of Tumors. Cancers 2019, 11, 1679. [Google Scholar] [CrossRef] [Green Version]
- Sambi, M.; DeCarlo, A.; Malardier-Jugroot, C.; Szewczuk, M. Next-Generation Multimodality of Nanomedicine Therapy: Size and Structure Dependence of Folic Acid Conjugated Copolymers Actively Target Cancer Cells in Disabling Cell Division and Inducing Apoptosis. Cancers 2019, 11, 1698. [Google Scholar] [CrossRef] [Green Version]
- Razura-Carmona, F.; Pérez-Larios, A.; González-Silva, N.; Herrera-Martínez, M.; Medina-Torres, L.; Sáyago-Ayerdi, S.; Sánchez-Burgos, J. Mangiferin-Loaded Polymeric Nanoparticles: Optical Characterization, Effect of Anti-topoisomerase I. and Cytotoxicity. Cancers 2019, 11, 1965. [Google Scholar] [CrossRef] [Green Version]
- Shih, F.; Jiang, W.; Lin, X.; Kuo, S.; Huang, G.; Hou, Y.; Chang, C.; Liu, Y.; Chiang, Y. A Novel pH-Tunable Secondary Conformation Containing Mixed Micellar System in Anticancer Treatment. Cancers 2020, 12, 503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Argenziano, M.; Gigliotti, C.; Clemente, N.; Boggio, E.; Ferrara, B.; Trotta, F.; Pizzimenti, S.; Barrera, G.; Boldorini, R.; Bessone, F.; et al. Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models. Cancers 2020, 12, 162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tabish, T.; Pranjol, M.; Horsell, D.; Rahat, A.; Whatmore, J.; Winyard, P.; Zhang, S. Graphene Oxide-Based Targeting of Extracellular Cathepsin D and Cathepsin L As A Novel Anti-Metastatic Enzyme Cancer Therapy. Cancers 2019, 11, 319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bugárová, N.; Špitálsky, Z.; Mičušík, M.; Bodík, M.; Šiffalovič, P.; Koneracká, M.; Závišová, V.; Kubovčíková, M.; Kajanová, I.; Zaťovičová, M.; et al. A Multifunctional Graphene Oxide Platform for Targeting Cancer. Cancers 2019, 11, 753. [Google Scholar] [CrossRef] [Green Version]
- Hasan, M.; Campbell, E.; Sizova, O.; Lyle, V.; Akkaraju, G.; Kirkpatrick, D.; Naumov, A. Multi-Drug/Gene NASH Therapy Delivery and Selective Hyperspectral NIR Imaging Using Chirality-Sorted Single-Walled Carbon Nanotubes. Cancers 2019, 11, 1175. [Google Scholar] [CrossRef] [Green Version]
- Naletova, I.; Cucci, L.; D’Angeli, F.; Anfuso, C.; Magrì, A.; La Mendola, D.; Lupo, G.; Satriano, C. A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain Tumours. Cancers 2019, 11, 1322. [Google Scholar] [CrossRef] [Green Version]
- Latorre, A.; Latorre, A.; Castellanos, M.; Rodriguez Diaz, C.; Lazaro-Carrillo, A.; Aguado, T.; Lecea, M.; Romero-Pérez, S.; Calero, M.; Sanchez-Puelles, J.; et al. Multifunctional Albumin-Stabilized Gold Nanoclusters for the Reduction of Cancer Stem Cells. Cancers 2019, 11, 969. [Google Scholar] [CrossRef] [Green Version]
- Nana, A.; Marimuthu, T.; Kondiah, P.; Choonara, Y.; Du Toit, L.; Pillay, V. Multifunctional Magnetic Nanowires: Design, Fabrication, and Future Prospects as Cancer Therapeutics. Cancers 2019, 11, 1956. [Google Scholar] [CrossRef] [Green Version]
- Winter, A.; Engels, S.; Goos, P.; Süykers, M.; Gudenkauf, S.; Henke, R.; Wawroschek, F. Accuracy of Magnetometer-Guided Sentinel Lymphadenectomy after Intraprostatic Injection of Superparamagnetic Iron Oxide Nanoparticles in Prostate Cancer: The SentiMag Pro II Study. Cancers 2020, 12, 32. [Google Scholar] [CrossRef] [Green Version]
- Ovejero Paredes, K.; Díaz-García, D.; García-Almodóvar, V.; Lozano Chamizo, L.; Marciello, M.; Díaz-Sánchez, M.; Prashar, S.; Gómez-Ruiz, S.; Filice, M. Multifunctional Silica-Based Nanoparticles with Controlled Release of Organotin Metallodrug for Targeted Theranosis of Breast Cancer. Cancers 2020, 12, 187. [Google Scholar] [CrossRef] [Green Version]
- Wu, Z.; Lee, C.; Lin, H. Hyaluronidase-Responsive Mesoporous Silica Nanoparticles with Dual-Imaging and Dual-Target Function. Cancers 2019, 11, 697. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ali, M.; Farghali, H.; Wu, Y.; El-Sayed, I.; Osman, A.; Selim, S.; El-Sayed, M. Gold Nanorod-Assisted Photothermal Therapy Decreases Bleeding during Breast Cancer Surgery in Dogs and Cats. Cancers 2019, 11, 851. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kolosnjaj-Tabi, J.; Kralj, S.; Griseti, E.; Nemec, S.; Wilhelm, C.; Plan Sangnier, A.; Bellard, E.; Fourquaux, I.; Golzio, M.; Rols, M. Magnetic Silica-Coated Iron Oxide Nanochains as Photothermal Agents, Disrupting the Extracellular Matrix and Eradicating Cancer Cells. Cancers 2019, 11, 2040. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Loiseau, A.; Boudon, J.; Oudot, A.; Moreau, M.; Boidot, R.; Chassagnon, R.; Mohamed Saïd, N.; Roux, S.; Mirjolet, C.; Millot, N. Titanate Nanotubes Engineered with Gold Nanoparticles and Docetaxel to Enhance Radiotherapy on Xenografted Prostate Tumors. Cancers 2019, 11, 1962. [Google Scholar] [CrossRef] [Green Version]
- Mukherjee, A.; Paul, M.; Mukherjee, S. Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer. Cancers 2019, 11, 597. [Google Scholar] [CrossRef] [Green Version]
- Yoo, J.; Park, C.; Yi, G.; Lee, D.; Koo, H. Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems. Cancers 2019, 11, 640. [Google Scholar] [CrossRef] [Green Version]
- Moku, G.; Layek, B.; Trautman, L.; Putnam, S.; Panyam, J.; Prabha, S. Improving Payload Capacity and Anti-Tumor Efficacy of Mesenchymal Stem Cells Using TAT Peptide Functionalized Polymeric Nanoparticles. Cancers 2019, 11, 491. [Google Scholar] [CrossRef] [Green Version]
- Darguzyte, M.; Drude, N.; Lammers, T.; Kiessling, F. Riboflavin-Targeted Drug Delivery. Cancers 2020, 12, 295. [Google Scholar] [CrossRef] [Green Version]
- Wu, P.; Opadele, A.; Onodera, Y.; Nam, J. Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy. Cancers 2019, 11, 1783. [Google Scholar] [CrossRef] [Green Version]
- Houdaihed, L.; Evans, J.; Allen, C. In Vivo Evaluation of Dual-Targeted Nanoparticles Encapsulating Paclitaxel and Everolimus. Cancers 2019, 11, 752. [Google Scholar] [CrossRef] [Green Version]
- Shurbaji, S.G.; Anlar, G.A.; Hussein, E.; Elzatahry, A.C.; Yalcin, H. Effect of Flow-Induced Shear Stress in Nanomaterial Uptake by Cells: Focus on Targeted Anti-Cancer Therapy. Cancers 2020, 12, 1916. [Google Scholar] [CrossRef] [PubMed]
- Feng, J.; Byrne, N.; Al Jamal, W.; Coulter, J. Exploitng Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development. Cancers 2019, 11, 1989. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Santos-Rebelo, A.; Kumar, P.; Pillay, V.; Choonara, Y.; Eleutério, C.; Figueira, M.; Viana, A.; Ascensão, L.; Molpeceres, J.; Rijo, P.; et al. Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells. Cancers 2019, 11, 1733. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Susa, F.; Limongi, T.; Dumontel, B.; Vighetto, V.; Cauda, V. Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine. Cancers 2019, 11, 1979. [Google Scholar] [CrossRef] [Green Version]
- Wang, G.; Hu, W.; Chen, H.; Shou, X.; Ye, T.; Xu, Y. Cocktail Strategy Based on NK Cell-Derived Exosomes and Their Biomimetic Nanoparticles for Dual Tumor Therapy. Cancers 2019, 11, 1560. [Google Scholar] [CrossRef] [Green Version]
- Harris, J.; Scully, M.; Day, E. Cancer Cell Membrane-Coated Nanoparticles for Cancer Management. Cancers 2019, 11, 1836. [Google Scholar] [CrossRef] [Green Version]
- Ben-David-Naim, M.; Dagan, A.; Grad, E.; Aizik, G.; Nordling-David, M.; Morss Clyne, A.; Granot, Z.; Golomb, G. Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy. Cancers 2019, 11, 442. [Google Scholar] [CrossRef] [Green Version]
- Kamaruzman, N.; Aziz, N.; Poh, C.; Chowdhury, E. Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer. Cancers 2019, 11, 632. [Google Scholar] [CrossRef] [Green Version]
- Sau, S.; Petrovici, A.; Alsaab, H.; Bhise, K.; Iyer, A. PDL-1 Antibody Drug Conjugate for Selective Chemo-Guided Immune Modulation of Cancer. Cancers 2019, 11, 232. [Google Scholar] [CrossRef] [Green Version]
- Kerstetter-Fogle, A.; Shukla, S.; Wang, C.; Beiss, V.; Harris, P.; Sloan, A.; Steinmetz, N. Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy. Cancers 2019, 11, 515. [Google Scholar] [CrossRef] [Green Version]
- Di Mascolo, D.; Varesano, S.; Benelli, R.; Mollica, H.; Salis, A.; Zocchi, M.; Decuzzi, P.; Poggi, A. Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer. Cancers 2020, 12, 104. [Google Scholar] [CrossRef] [Green Version]
- Cortese, B.; D’Amone, S.; Testini, M.; Ratano, P.; Palamà, I. Hybrid Clustered Nanoparticles for Chemo-Antibacterial Combinatorial Cancer Therapy. Cancers 2019, 11, 1338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, J.; Moon, H.; Han, H.; Lee, I.; Kim, D.; Lee, H.; Ha, S.; Kim, H.; Chung, J. Antitumor Effects of Intra-Arterial Delivery of Albumin-Doxorubicin Nanoparticle Conjugated Microbubbles Combined with Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver Tumors. Cancers 2019, 11, 581. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Meng, F.; Sun, Y.; Lee, R.; Wang, G.; Zheng, X.; Zhang, H.; Fu, Y.; Yan, G.; Wang, Y.; Deng, W.; et al. Folate Receptor-Targeted Albumin Nanoparticles Based on Microfluidic Technology to Deliver Cabazitaxel. Cancers 2019, 11, 1571. [Google Scholar] [CrossRef] [Green Version]
- Salvioni, L.; Rizzuto, M.; Bertolini, J.; Pandolfi, L.; Colombo, M.; Prosperi, D. Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope. Cancers 2019, 11, 1855. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pantshwa, J.; Kondiah, P.; Choonara, Y.; Marimuthu, T.; Pillay, V. Nanodrug Delivery Systems for the Treatment of Ovarian Cancer. Cancers 2020, 12, 213. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hoskins, C. Cancer Nanomedicine. Cancers 2020, 12, 2127. https://doi.org/10.3390/cancers12082127
Hoskins C. Cancer Nanomedicine. Cancers. 2020; 12(8):2127. https://doi.org/10.3390/cancers12082127
Chicago/Turabian StyleHoskins, Clare. 2020. "Cancer Nanomedicine" Cancers 12, no. 8: 2127. https://doi.org/10.3390/cancers12082127